Ian C. Cook, MD, discusses the feasibility and benefits of adding bilateral salpingectomy to nongynecologic surgery.
Guideline concordant osimertinib and durvalumab in two US non-small cell lung cancer cohorts. This is an ASCO Meeting Abstract from the 2025 ASCO Quality Care Symposium. This abstract does not include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results